By the same token, the sera level of ICAM-1 was highly elevated among primary and secondary APS patients to 2.2-fold (P < 0.0001) and 3.5-fold (P < 0.0001), respectively, compared to healthy subjects. This evidence concerns the gene ICAM1 and autoimmune polyendocrinopathy.